Navigation Links
American Chemical Society's Weekly PressPac -- March 26, 2008
Date:3/31/2008

ail: vanetten@ag.arizona.edu


ARTICLE #3 FOR IMMEDIATE RELEASE

Chemical signaling may power nanomachines
ACS Nano

In a finding that could provide controlled motion in futuristic nanomachines used for drug delivery, fuel cells, and other applications, researchers in Pennsylvania report that chemical signaling between synthetic microcapsules can trigger and direct movement of these capsules. Their study is scheduled for the currrent isssue of ACS Nano, a monthly journal.

Researchers theorize that synthetic capsules can communicate with each other by physically shuffling chemical signals from capsule to capsule, much like passing water through a firemans bucket brigade. Scientists recently suggested that this same signaling process also appears capable of sending cues to direct cell movement.

In the new study, Anna C. Balazs and colleagues used computer models to simulate the chemical signaling. They modeled a porous polymer microcapsule filled with nanonparticles to imitate a biological cell. When placed next to an empty capsule, nanoparticles from the filled capsule initiated the motion of the empty capsule, which in turn caused the movement of the filled signaling capsule. The same locomotion process could be engineered into futuristic nanomachines to help direct their movement through the body or through fuel cells, the researchers suggest. MTS

ARTICLE #3 FOR IMMEDIATE RELEASE Modeling Microcapsules That Communicate through Nanoparticles To Undergo Self-Propelled Motion

DOWNLOAD FULL TEXT ARTICLE http://dx.doi.org/10.1021/nn700379v

CONTACT:
Anna C. Balazs, Ph.D.
University of Pittsburgh
Pittsburgh, Pennsylvania 15261
Phone: 412-648-9250
Fax: 412-624-9639
Email: balazs1@engr.pitt.edu


'/>"/>
Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
American Chemical Society's Weekly PressPac -- March 26, 2008
American Chemical Society's Weekly PressPac -- March 26, 2008
Breaking Biology News(10 mins):New inherited eye disease discovered 2Introns: A mystery renewed 2Introns: A mystery renewed 3Introns: A mystery renewed 4Experts: Disease-resistant plants enhance profits, client satisfaction 2Olympus Managed Health Care Nominated for Prestigious International Award 57106 1Olympus Managed Health Care Nominated for Prestigious International Award 57106 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 1American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 2American Scientific Resources Acquires Intellectual Property to Worlds Only FDA Approved Home Needle Destruction Device 57103 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 1Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 2Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 3Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 4Data From Optimers Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 28ICAAC 5001 5
Breaking Biology Technology:Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3